New Segment of Innovations TV to Focus on Breakthroughs in Human Cell Imaging Technology

Share Article

Exploring the evolving world of imaging cells in 3D.

News Image
"Molecular Devices is committed to the continual development of innovative solutions for life science applications."

In a new segment scheduled to be broadcasted in the 4th quarter 2018, Innovations with Ed Begley, Jr. will educate audiences on recent advances in high-throughput cellular imaging. Check your local listings for more information.

This segment will focus on Molecular Devices innovative high content imaging platform which enable scientists to improve productivity and effectiveness of cell biology research, ultimately accelerating the discovery of new therapeutics.

With over 140,000 placements in laboratories around the world, Molecular Devices instruments have catalyzed brilliant scientific research described in over 150,000 peer reviewed publications. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection.

"We are proud to be in the forefront of the life science industry with leading-edge products in imaging, microplate detection, biotherapeutics, and analysis software," said Greg Milosevich, President of Molecular Devices.

The company has over a 35-year history in innovation and quality and is over 1,100 associates strong with rich domain knowledge to support scientific breakthroughs.

“Molecular Devices is committed to the continual development of innovative solutions for life science applications,” said John Galvin, producer for the Innovations series. “We look forward to highlighting the technology and advancements taking place as a result of their research.”

About Molecular Devices:
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics.

Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California with offices around the globe.

For more information, visit: http://www.moleculardevices.com.

About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.

Backed by experts in various fields, and a team dedicated to education and advancement, DMG Productions consistently produces commercial-free, educational programming on which both viewers and networks depend.

For more information visit: http://www.InnovationsTelevision.com or call (866) 496-4065.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah
Visit website